<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03445481</url>
  </required_header>
  <id_info>
    <org_study_id>ORL ORT 001</org_study_id>
    <nct_id>NCT03445481</nct_id>
  </id_info>
  <brief_title>Clinical Pilot Study of New Prosthesis for Trans-femoral Amputated Patients</brief_title>
  <official_title>Pilot Study of New Prosthesis for Trans-femoral Amputated Patients Clinical Study Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Christian Candrian</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ente Ospedaliero Cantonale, Bellinzona</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with a trans-femoral amputation who experienced problems, complications pain due to
      the ischial weight bearing and discomfort with conventional socket prosthesis will be
      proposed to implant a new developed prosthesis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patients will undergo a surgical operation to implant a femoral prosthesis according to
      the hospital's protocol. The surgical intervention will be performed under general or spinal
      anesthesia with a tourniquet at the root of the lower limb. Under sterile conditions, the
      incision of the stump will be done at the level of the previous surgical scar. Preserving the
      soft tissue, the distal femoral bone is reached. Then, the medullary canal is opened and
      prepared with reamers of increasing diameter. A femoral cemented stem of appropriate
      dimensions correlated to the size of the canal and 105 mm of height is implanted. To the
      above-mentioned stem, the Medacta prosthesis will be fixed with a blocking screw. The
      prosthesis is then covered with the soft tissue and layered suturing of the stump is
      performed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 20, 2018</start_date>
  <completion_date type="Anticipated">February 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Two years</time_frame>
    <description>Patients outcome evaluation of health-related quality of life through quality of life questionnaire EQ-5D-5L</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Two years</time_frame>
    <description>Post surgery adverse events collecting adverse events</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Trans-femoral Amputated Patients</condition>
  <arm_group>
    <arm_group_label>Femoral prosthesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>newly developed prosthesis for trans-femoral amputation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medacta femoral prosthesis</intervention_name>
    <description>patients' treatment with a new implant prosthesis</description>
    <arm_group_label>Femoral prosthesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18 and &lt;75 years

          -  Patients with Trans-femoral Amputations since at least 2 years and suffering from pain
             and discomfort with the current standard socket prosthesis, i.e., with a baseline VAS
             score for pain between 3 and 10 or a health-related quality of life (Eq-5D) score &lt; 60
             or an SF-36 result below the 50th percentile

          -  Amputation due to:

               1. Trauma

               2. Oncologic disease

          -  Written informed consent

        Exclusion Criteria:

          -  Trans-femoral amputation due to infection

          -  Patients affected by

               1. metabolic disease

               2. neurologic degenerative disease

               3. vascular disease proximal to the amputation

               4. body weight &gt;100 kg

               5. Hip arthritis of the amputated limb
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Candrian, Dr. med</last_name>
    <role>Principal Investigator</role>
    <affiliation>EOC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian Candrian, Dr. med</last_name>
    <phone>+41 (0) 91 811 61 23</phone>
    <email>christian.candrian@eoc.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marco Delcogliano, Dr. med</last_name>
    <phone>+41 (0) 91 811 66 56</phone>
    <email>marco.delcogliano@eoc.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ospedale Regionale di Lugano Civico e Italiano</name>
      <address>
        <city>Lugano</city>
        <zip>6900</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Candrian, MD</last_name>
      <phone>+41 (0) 91 811 61 23</phone>
      <email>christian.candrian@eoc.ch</email>
    </contact>
    <contact_backup>
      <last_name>Marco Delcogliano, MD</last_name>
      <phone>+41 (0) 91 811 66 56</phone>
      <email>marco.delcogliano@eoc.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2018</study_first_submitted>
  <study_first_submitted_qc>February 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2018</study_first_posted>
  <last_update_submitted>February 23, 2018</last_update_submitted>
  <last_update_submitted_qc>February 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ente Ospedaliero Cantonale, Bellinzona</investigator_affiliation>
    <investigator_full_name>Christian Candrian</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>not foreseen</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

